Risk of secondary hemorrhage; topical corticosteroids · people with traumatic hyphema
It is very uncertain whether systemic or topical corticosteroids changes risk of secondary hemorrhage; topical corticosteroids compared with placebo or control treatment (very low certainty).
1 finding from 1 review
Proportion of participants with best‐corrected visual acuity of 20/40 1 week · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with cystoid macular edema 1 week · people who received phacoemulsification
Summary of findings for NSAIDs plus corticosteroids may leads to lower proportion of participants with cystoid macular edema 1 week compared with corticosteroids alone (low certainty).
1 finding from 1 review
Time to cessation of treatment · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Economic outcomes · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraocular inflammation measured by anterior chamber cell and flare 1 week · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intraocular inflammation measured by proportion of participants with corneal edema 1 week · people who received phacoemulsification
Summary of findings for NSAIDs plus corticosteroids showed no clear difference in intraocular inflammation measured by proportion of participants with… compared with corticosteroids alone (moderate certainty).
1 finding from 1 review
Poor vision due to MO at 3 months after surgery · patients undergoing cataract surgery
NSAIDS plus steroids may leads to lower poor vision due to MO at 3 months after surgery compared with steroids (low certainty).
1 finding from 1 review
Poor vision due to MO at 12 months after surgery · patients undergoing cataract surgery
It is very uncertain whether NSAIDS plus steroids changes poor vision due to MO at 12 months after surgery compared with steroids (very low certainty).
1 finding from 1 review
Quality of life at 3 months after surgery · patients undergoing cataract surgery
1 finding from 1 review
Central retinal thickness at 3 months after surgery; · patients undergoing cataract surgery
1 finding from 1 review
Adverse effects · patients undergoing cataract surgery
1 finding from 1 review
MO at 3 months after cataract surgery, clinically symptomatic, · patients undergoing cataract surgery
NSAIDS plus steroids may leads to lower MO at 3 months after cataract surgery, clinically symptomatic, compared with steroids (low certainty).
1 finding from 1 review
Mean postoperative best‐corrected visual acuity · patients undergoing cataract surgery
1 finding from 1 review
Length of hospital stay · patients age 10 years and older with periorbital or orbital cellulitis
It is very uncertain whether standard treatment plus systemic corticosteroids changes length of hospital stay compared with standard treatment alone (very low certainty).
1 finding from 1 review
Preservation of visual acuity · patients age 10 years and older with periorbital or orbital cellulitis
It is very uncertain whether standard treatment plus systemic corticosteroids changes preservation of visual acuity compared with standard treatment alone (very low certainty).
1 finding from 1 review
Severity of pain on day 3 · patients age 10 years and older with periorbital or orbital cellulitis
It is very uncertain whether standard treatment plus systemic corticosteroids changes severity of pain on day 3 compared with standard treatment alone (very low certainty).
1 finding from 1 review
Duration of time requiring intravenous antibiotics · patients age 10 years and older with periorbital or orbital cellulitis
It is very uncertain whether standard treatment plus systemic corticosteroids changes duration of time requiring intravenous antibiotics compared with standard treatment alone (very low certainty).
1 finding from 1 review
Surgical intervention · patients age 10 years and older with periorbital or orbital cellulitis
It is very uncertain whether standard treatment plus systemic corticosteroids changes need for surgical intervention compared with standard treatment alone (very low certainty).
1 finding from 1 review